Medical Advocates

HCV Infection/Disease
  Oncology

General Reports
Hepatocellular Carcinoma

Lymphoma         
Leiomyosarcoma






 

HCV Main Page Main New/Newsworthy    Home Page    

Last Update:  July 06, 2017
   
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader


General Reports
 

     Journal Papers, Abstracts, and Commentaries
 
 
Hepatitis C virus infection and risk of multiple myeloma: evidence from a meta-analysis based on 17 case-control studies.
Li Y, Li Y, Zhang L, Li W.
J Viral Hepat. 2017 Jun 28
Abstract

The path to cancer, and back: Immune modulation during hepatitis C virus infection, progression to fibrosis and cancer, and unexpected roles of new antivirals.
Debes JD, de Knegt RJ, Boonstra A.
Transplantation
. 2016 Dec 30.
Abstract

FULL-TEXT ARTICLE
Hepatitis C infection and renal cell carcinoma: A systematic review and meta-analysis.
Wijarnpreecha K, Nissaisorakarn P, Sornprom S,  et al
World J Gastrointest Pathophysiol. 2016 Nov 15;7(4):314-319.
Paper

Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer.
Economides MP, Mahale P, Kyvernitakis A, et al
Aliment Pharmacol Ther
. 2016 Oct 11.
Abstract

Evaluation of serum levels and significance of soluble CD40 ligand in screening patients with hepatitis C virus-related hepatocellular carcinoma
Eltaher SM, El-Gil R, Fouad N, Mitwali R, El-Kholy H.
East Mediterr Health J
. 2016 Nov 2;22(8):603-610
Abstract

A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.
Wijetunga NA, Pascual M, Tozour J, et a;;
Oncogene. 2016 Oct 10.
Abstract

How we treat hepatitis C virus infection in patients with hematologic malignancies.
Torres HA, McDonald GB.
Blood
. 2016 Jul 21
Abstract

FULL-TEXT ARTICLE
HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
Carrier P,
Jaccard A, Jacques J, et al 
Liver Int. 2015 Jun 22

Paper

Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN, Youssef AS, El-Desouky ED,
Tumour Biol. 2016 Jun 6
Abstract

Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy.
Lin JW, Chang ML, Hsu CW,
J Med Virol. 2016 Jun 8.
Abstract

FULL-TEXT ARTICLE

In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
Canioni D, Michot JM, Rabiega P, et al
PLoS One. 2016 Jun 3;11(6):e0156384.
Paper

Association Between Hepatitis C Virus and Head and Neck Cancers.
Mahale P, Sturgis EM, Tweardy DJ,
J Natl Cancer Inst. 2016 Apr 13;108(8).
Abstract

FULL-TEXT ARTICLE
Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection.
Kedia S, Bhatt VR, Rajan SK, et al
Int J Prev Med
. 2014 Dec;5(Suppl 3):S179-92. Review
Paper

Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.
Fiorino S, Bacchi-Reggiani L, de Biase D, et al
World J Gastroenterol
. 2015 Dec 7;21(45):12896-953.
Abstract

Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma.
Sugimoto K, Kim SR, Kim SK, et al
Oncology
. 2015 Nov;89 Suppl 2:42-46
Abstract

How do persistent infections with hepatitis C virus cause liver cancer?
Mitchell JK, Lemon SM, McGivern DR
Curr Opin Virol
. 2015 Sep 28;14:101-108.
 
Abstract

Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.
Chen CL, Tsukamoto H, Machida K.
Hepatol Int
. 2014 Jul;8(3):330-8.
Abstract

Impact of hepatitis C virus eradication on hepatocellular carcinogenesis.
Li DK, Chung RT.
Cancer. 2015 Jun 16. 
Abstract

Increased Incidence of Cancer and Cancer-related Mortality Among Persons with Chronic Hepatitis C Infection, 2006-2010.
Allison RD, Tong X, Moorman AC, et al
J Hepatol. 2015 Apr 30
Abstract

FULL-TEXT PDF ARTICLE
Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
Li H, Hu B, Zhou ZQ, et al
World J Surg Oncol
. 2015 Apr 23;13(1):161

Paper

Chronic Hepatitis C Infection as a Risk Factor for Renal Cell Carcinoma.
Gonzalez HC, Lamerato L, Rogers CG, Gordon SC.
Dig Dis Sci. 2015 Jan 17.
Abstract. .

Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population.
Torres HA, Mahale P, Blechacz B, et al
Natl Compr Canc Netw. 2015 Jan;13(1):41-50.
Abstract. .

Hepatitis C Virus-Associated Cancer.
Lin MV, King LY, Chung RT.
Annu Rev Pathol. 2014 Nov 5
Abstract. .

Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis C?
Pocha C, Knott A, Rector TS, Dieperink E.
J Clin Psychiatry
. 2014 Oct;75(10):e1122-e1126.
Abstract. .

The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection.
Tomizawa K, Suyama K, Matoba S, et al
Med Oncol
. 2014 Oct;31(10):212
Abstract. .

Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modeling of HCV kinetics.
Dahari H, Shteing
art S, Gafanovich I, et al 

Liver Int. 2014 Sep 23.
Abstract

FULL-TEXT ARTICLE
Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies.
Lee MH, Lu SN, Yuan Y, et al.
PLoS One
. 2014 May 6;9(5):e94760.
Paper

The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: A multicenter analysis by Osaka Hepatic Surgery Study Group.
Uenishi T, Nagano H, Marubashi S, et al
J Surg Oncol. 2014 Apr 24
Abstract

A rare presentation of multiple primary squamous cell carcinoma of the tongue in a patient with recurrent hepatitis C infection.
Stoopler ET, Sia YW, Chalian AA,  
Spec Care Dentist. 2014 Mar;34(2):96-9.
Abstract

Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.
Reddy A, May E, Ehrinpreis M, Mutchnick M.
World J Gastroenterol. 2013 Dec 28;19(48):9328-33.
Abstract

FULL-TEXT ARTICLE
Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection.
Lu T, Seto WK, Zhu RX, et al
World J Gastroenterol
. 2013 Dec 2
1
Paper

FULL-TEXT ARTICLE

HBV- and HCV-Related Infections and Risk of Pancreatic Cancer.
Fiorino S, Cuppini A, Castellani G,  et al
JOP. 2013 Nov 10;14(6):603-9.
Paper

Does Chemotherapy Cause Viral Relapse in Cancer Patients with Hepatitis C Infection Successfully Treated with Antivirals?
Mahale P, Okhuysen PC, Torres HA.
Clin Gastroenterol Hepatol
. 2013 Nov 7.
Abstract

FULL-TEXT ARTICLE
The safety of chemotherapy for breast cancer patients with hepatitis C virus infection.
Miura Y, Theriault RL, Naito Y,  
J Cancer. 2013 Jul 24;4(6):519-23.
Paper

An Analysis of Content in Comprehensive Cancer Control Plans that Address Chronic Hepatitis B and C Virus Infections as Major Risk Factors for Liver Cancer.
Momin B, Richardson L.

J Community Health
. 2011 Dec 9.
Abstract

FULL-TEXT ARTICLE
Malignancies associated with chronic hepatitis C: case report and review of the literature.
Vlaar AP, Rietdijk ST, Zeerleder SS, et al
Neth J Med. 2011 May;69(5):211-5..
Paper

New Sarcomatoid Cancer Cell Line SAR-HCV Established from a Hepatitis C Virus-related Liver
Tumour Lesion.
Tai DI, Shen YJ, Weng WH,  et al
Anticancer Res
. 2011 Jan;31(1):129-137.
Abstract

A Comparison of Prognosis between Patients with Hepatitis B and C Virus-related Hepatocellular
Carcinoma Undergoing Resection Surgery.
Kao WY, Su CW, Chau GY, et al
Worl
d J Surg. 2011 Jan
Abstract

Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European
Prospective Investigation into Cancer and Nutrition (EPIC).
Franceschi S, Lise M, Trepo C, et al
Cancer Epidemiol Biomarkers Prev
. 2010 Nov 23
Abstract

Interaction between cigarette smoking and hepatitis B and C virus infection
on the risk of liver cancer: a meta-analysis.
Chuang SC, Lee YC, Hashibe M,  et al
Cancer Epidemiol Biomarkers Prev
. 2010 May;19(5):1261-8.
Abstract


Hepatocellular Carcinoma
 

     Journal Papers, Abstracts, and Commentaries

 
Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
Cheng Y, Ping J, Chen J.
Pathol Oncol Res. 2017 Jul 1.
Abstract

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma
Mansour LA, El Raziky M, Mohamed AA,
Asian Pac J Cancer Prev
. 2017 Jun 25
Abstract

FULL-TEXT ARTICLE
On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C
Chu PS, Nakamoto N, Taniki N, et al
PLoS One
. 2017 Jun 15
Paper

Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
El-Mesery M, El-Mowafy M, Elgaml A, et al
J Interferon Cytokine Res
. 2017 Jun 13.|
Abstract

Potential ultrastructure predicting factors for hepatocellular carcinoma in HCV infected patients.
Mansy SS, El-Ahwany E, Mahmoud S, . et al
Ultrastruct Pathol
. 2017 May 11:1-18.
Abstract

Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease.
Ogata F, Kobayashi M, Akuta N,  et al
Oncology
. 2017 Apr 28.
Abstract

The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma.
Chinchilla-López P, Qi X, Yoshida EM, Méndez-Sánchez N.
A
nn Hepatol
. 2017 May - Jun 2017;16(3):328-330.
Abstract

Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib.
Kawaoka T, Aikata H, Teraoka Y,  et al
Oncology
.
2017 Mar 1.
Abstract

Challenges in Treatment of Hepatitis C among Patients with Hepatocellular Carcinoma.
Saberi B, Dadabhai AS, Durand CM, Philosophe B,  et al
Hepatology. 2017 Feb 17.
Abstract

Risk of End Stage Liver Disease, Hepatocellular Carcinoma and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort.
Bruden DJ, McMahon BJ, Townshend-Bulson L,  et al
Hepatology. 2017 Feb 13.
Abstract

Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy with Direct-Acting Antivirals.
Prenner S, VanWagner LB, Flamm SL
J Hepatol. 2017 Feb 1..
Abstract

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance
Huang CF, Yeh ML, Huang CI,  et al 
Oncotarget
. 2017 Feb 1.
Abstract

A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.
Cabibbo G, Petta S, Barbàra M, et al
 
Liver Int
. 2017 Jan 6
Abstract

Hepatocellular Carcinoma is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
Yang JD, Larson JJ, Watt KD,  et al
Clin Gastroenterol Hepatol. 2016 Dec 21.
Abstract

Evaluation of serum levels and significance of soluble CD40 ligand in screening patients with hepatitis C virus-related hepatocellular carcinoma.
Eltaher SM, El-Gil R, Fouad N, et al
East Mediterr Health J
. 2016 Nov 2;22(8):603-610.

Abstract

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.
Petta S, Cabibbo G, Barbara M, et al
Aliment Pharmacol Ther. 2016 Oct 28.
Abstract

Identification of Circulating Protein Biomarkers in Patients with Hepatocellular Carcinoma Concomitantly Infected with Chronic Hepatitis C Virus.
Abdel-Wahab AA, El-Halawany MS, Emam AA, et al
Biomarkers
. 2016 Oct 28:1-26.

Abstract

Infection With Hepatitis C Virus Genotype 3 is an Independent Risk Factor for End-stage Liver Disease, Hepatocellular Carcinoma, and Liver-related Death.
McMahon BJ, Bruden D, Townshend-Bulson L,  et al
Clin Gastroenterol Hepatol
. 2016 Oct 17.
Abstract

Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to Hepatitis C and Non Alcoholic Fatty Liver Disease.
Than NN, Ghazanfar A, Hodson J,
QJM. 2016 Sep 10.
Abstract

Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang JD, Mohamed HA, Cvinar JL,
Am J Gastroenterol. 2016 Aug 16.
Abstract

Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
Vallianou I, Dafou D, Vassilaki N, Mavromara P,
Int J Biochem Cell Biol. 2016 Jul 28.
Abstract

Molecular mechanisms of Hepatitis C virus-induced hepatocellular carcinoma.
Vescovo T, Refolo G, Vitagliano G, et al
Clin Microbiol Infect. 2016 Jul 28
Abstract

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir).
Ganne-Carrié N, Layese R, Bourcier V, et al  
Hepatology
. 2016 Jun 27.
Abstract

Diabetes and cirrhosis are risk factors for hepatocellular carcinoma after successful treatment of chronic hepatitis C.
Hedenstierna M, Nangarhari A, Weiland O, Aleman S.
Clin Infect Dis
. 2016 Jun 9
Abstract

Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy.
Lin JW, Chang ML, Hsu CW,
J Med Virol. 2016 Jun 8.
Abstract

Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4.
Moon J, Kaowinn S, Cho IR, et al
Biochem Biophys Res Commun
. 2016 May 2.
Abstract

Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.
Wu CK, Chang KC, Hung CH,  et al
J Antimicrob Chemother. 2016 Apr 12.
Abstract

How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?
Wang CC, Kao JH.
Expert Opin Pharmacother. 2016 Feb 1.
Abstract

FULL-TEXT ARTICLE
Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report
Honmyo N, Kobayashi T, Tashiro H,  et al
Int J Surg Case Rep
. 2016 Jan 22;20:96-100
Paper

Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis.
Tapper EB, Catana AM, Sethi N, et al
Cancer
. 2015 Dec
Abstract


Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.
Dyal HK, Aguilar M, Bartos G, et al 
Dig Dis Sci
. 2015 Dec 24
Abstract

Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma.
Tholey DM, Ahn J.
Gastroenterol Clin North Am
. 2015 Dec;44(4):761-73
Abstract

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.
Nagaoki Y, Aikata H, Nakano N, , et al
J Gastroenterol Hepatol
. 2015 Nov 19.

Abstract

Role of Locoregional Therapy and Predictors for Dropout in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.
Sheth RA, Patel MS, Koottappillil B, et al
J Vasc Interv Radiol. 2015 Sep 23.
Abstract

Subcutaneous metastasis - the first sign of hepatocellular carcinoma in chronic virus C hepatitis patient - Case report.
Ciortescu I, Rotariu A, Cozma DM,  et al
J Med Life. 2015 Jul-Sep;8(3):361-4.
Abstract

Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study.
Hiraoka A, Kumada T, Michitaka K,  et al
Hepatol Res. 2015 Aug 29. .
Abstract

Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy.
D'Ambrosio R, Della Corte C, Colombo M.
Int J Mol Sci. 2015 Aug 19;16(8):19698-19712.
Abstract

Hepatitis C virus-induced hepatocellular carcinoma.
Goossens N, Hoshida Y.
Clin Mol Hepatol. 2015 Jun;21(2):105-14.
Abstract

Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye.
Macaluso FS, Calvaruso V, Craxì A.
Future Microbiol. 2015 Jun;10:977-88.

Abstract

A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.
Zhang DY, Goossens N, Guo J, et al
Gut
. 2015 Jun 4
.
Abstract

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma.
Hsu CS, Chao YC, Lin HH,  et al
Sci Rep. 2015 May 12;5:9954.
Abstract

Hepatitis C Virus Infection, Antiviral Therapy, and Risk of Hepatocellular Carcinoma.
Hsu YC, Wu CY, Lin JT.
Semin Oncol
. 2015 Apr;42(2):329-338.
Abstract

A Comparison of Patients With Hepatitis B- or Hepatitis C-Based Advanced-Stage Hepatocellular Carcinoma.
Carr BI, Guerra V, Steel JL, Lu SN.
Semin Oncol
. 2015 Apr;42(2):309-315
Abstract

FULL-TEXT ARTICLE
Viruses in cancer cell plasticity: the role of hepatitis C virus in hepatocellular carcinoma.
Hibner U, Grégoire D.
Contemp Oncol
(Pozn)
. 2015;19(1A):A62-7.
Paper

Risk Factors of HCC Development in Non-cirrhotic Patients with Sustained Virologic Response for Chronic HCV Infection.
Toyoda H, Kumada T, Tada T, et al
J Gastroenterol Hepatol
. 2015 Feb 13.
Abstract

Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.
Labib HA, Ahmed HS, Shalaby SM,et al
Cell Immunol
. 2015 Jan 28. 
Abstract

Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC.
Viganò L, Conci S, Cescon M, Fava C, et al
J Hepatol
. 2015 Jan 31
Abstract

FULL-TEXT ARTICLE
Surgical approach for hepatitis C virus-related hepatocellular carcinoma.

Shindoh J, Hashimoto M, Watanabe G. et al 
World J Hepatol. 2015 Jan 27;7(1):70-7
Paper

Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.
Sumie S, Kawaguchi T, Kawaguchi A,. et al
Mol Clin Oncol
. 2015 Jan;3(1):115-120
Abstract

Laparoscopic left liver lobectomy for hepatocellular carcinoma in a cirrhotic patient: a video report.
Levi Sandri GB, Vennarecci G, Santoro R, et al
Chin J Cancer Res. 2014 Dec;26(6):735-6..
Abstract

Recurrent genetic alterations in hepatitis C-associated hepatocellular carcinoma detected by genomic microarray: a genetic, clinical and pathological correlation study.
Liu YJ, Zhou Y, Yeh MM.
Mol Cytogenet. 2014 Nov 25;7(1):81.
Abstract

Increased DNA Damage in Hepatitis C Virus-Related Hepatocellular Carcinoma.
Shawki SM, Meshaal SS, El Dash AS, et al
DNA Cell Biol. 2014 Sep 11

Abstract

Effect of Peginterferon alfa-2b and Ribavirin on Hepatocellular Carcinoma Prevention in Older Patients with Chronic Hepatitis C.
Honda T, Ishigami M, Hayashi H, et al
J Gastroenterol Hepato
l
. 2014 Aug 5.
Abstract

FULL-TEXT ARTICLE
Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma.
Peixoto RD, Renouf DJ, Gill S,  et al J
Gastrointest Oncol
. 2014 Aug;5(4):259-64
Paper

Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: Serum sodium predicts survival.
Biolato M, Miele L, Vero V, Racco S,  et al.
World J Gastroenterol
. 2014 Jul 7;20(25):8158-65.
Abstract

Intent-to-Treat Analysis of Liver Transplant for Hepatocellular Carcinoma in the MELD Era: Impact of Hepatitis C and Advanced Status.
Hu Z, Li Z, Xiang J, et al
Dig Dis Sci
. 2014 Jul 10..
Abstract

FULL-TEXT PDF ARTICLE
Effect of pre- and post-treatment alpha-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study.
Toro A, Ardiri A, Mannino M, Arcerito MC, et al
BMC Surg
. 2014 Jul 4;14(1):40.
Paper

FULL-TEXT ARTICLE
Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma.
Saito T, Chiba T, Suzuki E, Shinozaki M, et al
Int J Med Sci. 2014 May 7;11(7):707-12
Paper

Development of hepatocellular carcinoma in a non-cirrhotic, long-term responder to antiviral therapy, chronic hepatitis C patient: what kind of surveillance?
Bertolini E, Bassi F, Fornaciari G.  
Ann Gastroenterol
. 2013;26(1):80-83.
Abstract

Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach.
Mourad A, Deuffic-Burban S, Ganne-Carrié N,  et al
Hepatology. 2014 Apr;59(4):1471-81.
Abstract

Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011.
Di Benedetto N, Peralta M, Alvarez E,  et al
Ann Hepatol. 2013 Jan-2014 Feb;13(1):38-44.
Abstract

A New Laboratory Based Algorithm to Predict Development of Hepatocellular Carcinoma in Patients with Hepatitis C and Cirrhosis.
El-Serag HB, Kanwal F, Davila JA,  et al
Gastroenterology. 2014 Jan 23
Abstract

Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region.
Kim MN, Kim BK, Han KH.

J Gastroenterol
. 2013 Mar 6
Abstract

FULL-TEXT ARTICLE
A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus
patients with hepatocellular carcinoma.
Hernandez-Alejandro R, Croome KP, et al

World J Gastroenterol
. 2012 Aug 21;18(31):4145-9.
Paper

Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011.
Di Benedetto N, Peralta M, Alvarez E,  et al
Ann Hepatol. 2013 Jan-2014 Feb;13(1):38-44.
Abstract

Post-treatment Levels of α-fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy.
Oze T, Hiramatsu N, Yakushijin T,  et al
Clin Gastroenterol Hepatol
. 2013 Dec 6..

Abstract

FULL-TEXT ARTICLE
Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma.

Ishikawa T.
World J Gastroenterol
. 2013 Oct 7;19(37):6127-6130.
Paper

Second hepatectomy for recurrent hepatocellular carcinoma achieved sustained virological response to interferon therapy for hepatitis C.
Tsujita E, Yamashita YI, Takeishi K, et al
Hepatogastroenterology
. 2013 Oct 2;60(128
Abstract

Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy.
Chang KC, Wu YY, Hung CH,  et al
Br J Cancer. 2013 Oct 1.
Abstract

Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection: Further Evidence Is Warranted.
Bonovas S, Nikolopoulos G, Sitaras NM.
J Clin Oncol. 2013 Sep
Abstract

Mechanisms of HCV-induced liver cancer: What did we learn from in vitro and animal studies?
Rusyn I, Lemon SM.
Cancer Lett. 2013 Jul 18.
Abstract

Total serum glycan analysis is superior to Lectin-FLISA for the early detection of hepatocellular carcinoma.
Comunale MA, Wang M, Anbarasan N,  et al
Proteomics Clin Appl. 2013
Abstract

Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil.
Kikuchi L, Chagas AL, Alencar RS, et al
Antivir The
r
. 2013;18(3 Pt B):445-9
Abstract

The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Nishikawa H, Arimoto A, Wakasa T, et al
Gastroenterol Res Pract
. 2013;2013:430438.
Abstract

Hepatocellular Carcinoma in Chronic Hepatitis C in the Absence of Advanced Fibrosis or Cirrhosis.
Lewis S, Roayaie S, Ward SC, et al
AJR Am J Roentgenol
. 2013 Jun;200(6):W610-W616.
Abstract

A risk for hepatocellular carcinoma still persists long-term after sustained virological response in patients with hepatitis C associated liver cirrhosis.
Aleman S, Rahbin N, Weiland O, et al
Clin Infect Dis. 2013 Apr 24.
.
Abstract

Antiviral therapy after curative treatment of hepatitis B/C virus-related hepatocellular carcinoma: A systematic review of randomized trials.
Sun P, Yang X, He RQ, et al
Hepatol Res. 2013 Apr 2.
Abstract

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection.
Tsan YT, Lee CH, Ho WC,  et al
J Clin Oncol
. 2013 Mar 18.
Abstract

Infection with Hepatitis C Virus is an Adverse Prognostic Factor after Liver Resection for Early-stage Hepatocellular Carcinoma : Implications for the Management of Hepatocellular Carcinoma Eligible for Liver Transplantation.
Chirica M, Tranchart H, Tan V,  et al
Ann Surg Oncol. 2013 Jan 23.
Abstract

Hepatocarcinogenesis in Hepatitis C: HCV Shrewdly Exacerbates Oxidative Stress by Modulating
both Production and Scavenging of Reactive Oxygen Species.
Fujinaga H, Tsutsumi T, Yotsuyanagi H, et al
Oncology. 2011;81 Suppl 1:11-
Abstract

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are
decreased by alcohol.
Yamada M, Shiroeda H, Hayashi R, et al
J Clin Biochem Nutr
. 2011 Mar;48(2):167-9.
Abstract

Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with
Compensated Cirrhosis.
Velosa J, Serejo F, Marinho R, Nunes J, Glória H
Dig Dis Sci
.
2011 Mar 5
Abstract

High Levels of HCV core+1 Antibodies in HCV Patients with Hepatocellular Carcinoma.
Dalagiorgou G, Vassilaki N, Foka P, et al
J Gen Virol
. 2011 Feb 9.
Abstract

Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans
in the United States.
Davila JA, Henderson L, Kramer JR,  et al
Ann Intern Med
. 2011 Jan 18;
Abstract

A Comparison of Prognosis between Patients with Hepatitis B and C Virus-related Hepatocellular
Carcinoma Undergoing Resection Surgery.
Kao WY, Su CW, Chau GY,  et al
World J Surg
. 2011 Jan 5.
Abstract

Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the
prevention and treatment.
Castello G, Costantini S, Scala S.
J Transl Med. 2010 Nov 3;8(1):109
Abstract

FULL-TEXT ARTICLE
Insulin resistance is associated with hepatocellular carcinoma in chronic
hepatitis C infection.
Hung CH, Wang JH, Hu TH,  et al

World J Gastroenterol
. 2010 May 14;16(18):2265-71.
Paper

 

Lymphoma
 

General/Miscellaneous Reports

     Journal Papers, Abstracts, and Commentaries

 

Pancreatic lymphoma complicating early stage chronic hepatitis C.
Bhagat VH, Sepe T.
BMJ Case Rep. 2017 Jan 10;2017.
Abstract

FULL-TEXT ARTICLE
A case of peripheral T-cell lymphoma, not otherwise specified in a HCV and HTLV-II-positive patient, diagnosed by abdominal fluid cytology.
Ameri MD, Parekh TM, Qian YW,
J Gastrointest Oncol. 2016 Apr;7(Suppl 1

Paper

Lymphoma Remission by Interferon-Free HCV Eradication Without Chemotherapy.
Lim LY, La D, Cserti-Gazdewich CM, Shah H.
ACG Case Rep J. 2015 Oct 9;3(1):69-7..
Abstract

Lacrimal gland marginal zone lymphoma: regression after treatment of chronic hepatitis C virus infection: case report and review of the literature.
Coskun A, Yukselen O, Yukselen V, Karaoglu AO.
Intern Med. 2013;52(23):2615-8..
Abstract

Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era:
A single center experience.
Nishikawa H, Tsudo M, Osaki Y
Oncol Rep. 2012 Jun 25. .
Abstract

Primary effusion lymphoma of T-cell origin with t(7;8)(q32;q13) in an HIV-negative patient with
HCV-related liver cirrhosis and hepatocellular carcinoma positive for HHV6 and HHV8.
Nakayama-Ichiyama S, Yokote T, Kobayashi K, et al
Ann Hematol
. 2011 Feb 8.
Abstract
 

B-cell Lymphoma
 
     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma.

Ewers EC, Shah PA, Carmichael MG, Ferguson TM.
Open Forum Infect Dis. 2016 Dec 20;3(4):ofw223.
Paper
 

FULL=TEXT ARTICLE
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
Merli M, Carli G, Arcaini L, Visco C.
World J Gastroenterol. 2016 Oct 14;22
Paper

FULL-TEXT ARTICLE
Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.

Mihăilă RG.
World J Gastroenterol
. 2016 Jul 21;22(27):6214-23.
 

FULL-TEXT ARTICLE
HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
Carrier P, Jaccard A, Jacques J, et al
Liver Int. 2015 Jun 22
Paper

Prognostic impact of hepatitis C virus infection in patients with diffuse large B-cell lymphoma treated with immunochemotherapy in the context of a novel prognostic index.
Chen YY, Huang CE, Liang FW,  et al
Cancer Epidemiol
. 2015 Apr 18.
Abstract

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 Lympho-C study.
Michot JM, Canioni D, Driss H,  et al
Am J Hematol. 2014 Nov 21
Abstract

Clinical outcome of HCV-positive patients with diffuse large B-cell lymphoma treated with rituximab-based chemotherapy.
Salah-Eldin MA, Ebrahim MA, El-Sadda W.
Ann Hematol. 2014 Jun 21.
Abstract

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi
Arcaini L, Vallisa D, Rattotti S, Ferretti VV, et al
Ann Oncol
. 2014 May 5
Abstract

Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection.
Terrier B, Chaara W, Dufat L, et al
Autoimmun Rev. 2014 Mar;13(3):319-26.
Abstract

Hepatic toxicity and prognosis in HCV-infected patients with diffuse large B-cell lymphoma
treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis.
Ennishi D, Maeda Y, Niitsu N, et al
Blood
. 2010 Sep 7
Abstract

FULL-TEXT ARTICLE
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.

Merli M, Visco C, Spina M,  et al
Haematologica
. 2013 Nov 22
.
Paper

Non-Hodgkin's Lymphoma

     Journal Papers, Abstracts, and Commentaries
 

 
The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin's lymphomas.
Zhou X, Lisenko K, Lehners N,
Ann Hematol. 2017 Jul 1.
Abstract

Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?
Vannata B, Arcaini L, Zucca E.
Ther Adv Hematol. 2016 Apr;7(2):94-107.
Abstract

The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
Peveling-Oberhag J, Arcaini L, Bankov K, et al
J Viral Hepat. 2016 Feb 29.
Abstract

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 Lympho-C study.
Michot JM, Canioni D, Driss H,  et al
Am J Hematol. 2014 Nov 21
Abstract

Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in
chronic HCV infection.
Terrier B, Chaara W, Dufat L,  et al
Autoimmun Rev
. 2013 Nov 9.
Abstract

FULL-TEXT ARTICLE
Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.
Marignani M, Fonzo Md, Begini P, et al
World J Gastrointest Pharmacol T
her
. 2012 Apr 6;3(2):21-8.
Abstract

HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy:
Evidence and open questions.
Cox MC, Aloe-Spiriti MA, Cavalieri E,  et al
World J Gastrointest Oncol
. 2012 Mar 15;4(3):46-53.
Abstract

HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma
treated with rituximab-containing regimens.
Marignani M,
Dig Liver Dis. 2010 Jun 14
Abstract

HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questions.
Cox MC, Aloe-Spiriti MA, Cavalieri E,  et al
World J Gastrointest Oncol
. 2012 Mar 15;4(3):46-53.
Abstract

Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C
virus-related cryoglobulinaemia vasculitis.
Geri G, Terrier B, Semoun O, et al
Ann Rheum Dis
. 2010 Sep 27.
Abstract

 

Hodgkin Lymphoma

     Journal Papers, Abstracts, and Commentaries
 
  Regression of hodgkin lymphoma in response to antiviral therapy for hepatitis C virus infection.
Takahashi K, Nishida N, Kawabata H,
Intern Med
. 2012;51(19):2745-7. .
Abstract


Leiomyosarcoma
 

     Journal Papers, Abstracts, and Commentaries
 
  Leiomyosarcoma of the infrarenal portion of the inferior vena cava in a cirrhotic patient
with hepatitis C.

Delis S, Triantopoulou C, Bakoyiannis A, et al  
Abdom Imaging
. 2007 Mar 27;

Abstract
 
 


HCV Main Page Main New/Newsworthy    Home Page    

HCV Oncology